What is the rate of Treatment Related Adverse Events with CTCAE >= 3 at the RD for AZD0022 monotherapy in NCT06599502?

Ṁ73

Dec 31

ALL

56%

<= 10%

12%

<= 20% & >10%

12%

<= 30% & >20%

10%

<= 60% & >30%

10%

(<= 100% & >60%) OR termination due to high toxicity

The question is resolved based on data in the last publication related to this clinical trial. The question does not resolve if no results are reported within 6 months after the official end date 2028-01-20. If the trial is ended due to high toxicity, the last option is selected.

#Science

#clinical trials

Get

1,000

and

1.00

1 Comment

Sort by:

bought Ṁ40 <= 10% YES

Buying <= 10% based on previous results from Novartis https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.9007

Related questions

Related questions